CD44 and cancer: To validate the impact of the HH pathway in the regulation of CSCs that might play a fundamental role in the observed therapy resistance in patient derived tumor resection material, CD44+/CD24− was taken as a read-out for cancer stemness after first verifying the sphere forming ability, as a hallmark of CSCs, of this population in vitro.